NR3C2 and atherosclerosis: Aldo infusion in animal models of atherosclerosis, including the apolipoprotein E–knockout mouse (ApoE−/−), increases overall aortic plaque area with enhanced vascular and macrophage oxidative stress.22 Conversely, aldosterone synthase inhibitors23 and MR antagonists24–25 decrease atherosclerosis in animal models.